<DOC>
	<DOCNO>NCT00623363</DOCNO>
	<brief_summary>The purpose study obtain preliminary information effect piclozotan motor complication associate Parkinson 's Disease .</brief_summary>
	<brief_title>Preliminary Study Piclozotan Patients With Motor Complications Associated With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Piclozotan</mesh_term>
	<criteria>Main Idiopathic Parkinson 's disease least 5 year Presence motor fluctuation dyskinesia Stable regimen levodopa/carbidopa 30 day At least 25 % response/improvement UPDRS part III score dose regular PD medication MMSE score 25 high Main Atypical secondary parkinsonism . Prior use neuroleptic agent . History intracranial procedure PD . Active psychosis . History drug alcohol abuse past 12 month . Cardiac conduction system abnormality . Predisposing medical condition cause nausea vomit routine use antiemetic .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>motor complication</keyword>
	<keyword>dyskinesia</keyword>
	<keyword>Motor complication associate Parkinson 's</keyword>
</DOC>